Kalaris Therapeutics, Inc. - KLRS

  1. All Sectors
  2. Manufacturing
  3. Chemicals
  4. Biological Products, (no Disgnostic Substances)
Latest data: 12/10/2025 10:05:24 PM
EDGAR CIK 0001754068

Buy Breakdown

Total $0

Sell Breakdown

Total $16,043

Monthly Totals

Transaction Filed Name Type Shares @ Price Value Balance change Ownership
03/26/2025
03/27/2025
Hagen Brett R
Chief Accounting Officer
Officer
Sell
-907 @ $8.97
($8,135.16)
 1,925 (-32.03%) Direct
02/21/2025
02/24/2025
Hagen Brett R
Chief Accounting Officer
Officer
Sell
-96 @ $10.08
($967.28)
 2,832 (-3.28%) Direct
02/21/2025
02/24/2025
Miller Edward
General Counsel
Officer
Sell
-106 @ $10.08
($1,068.03)
 6,517 (-1.60%) Direct
02/21/2025
02/24/2025
Sinha Vikas
Officer Title: President, Chief Financial Officer
CEO Director 10% owner
Sell
-303 @ $10.08
($3,052.97)
 49,129 (-0.61%) Direct
01/23/2025
01/27/2025
Hagen Brett R
Chief Accounting Officer
Officer
Sell
-36 @ $9.51
($342.28)
 2,928 (-1.21%) Direct
01/23/2025
01/27/2025
Miller Edward
General Counsel
Officer
Sell
-52 @ $9.50
($494.03)
 6,623 (-0.78%) Direct
01/23/2025
01/27/2025
Sinha Vikas
Officer Title: President, Chief Financial Officer
CEO Director 10% owner
Sell
-129 @ $9.50
($1,225.86)
 49,432 (-0.26%) Direct
01/10/2025
01/13/2025
Hagen Brett R
Chief Accounting Officer
Officer
Sell
-332 @ $0.44
($146.11)
 68,174 (-0.48%) Direct
01/10/2025
01/13/2025
Miller Edward
General Counsel
Officer
Sell
-409 @ $0.44
($180.00)
 153,541 (-0.27%) Direct
01/10/2025
01/13/2025
Sinha Vikas
Officer Title: President, Chief Financial Officer
CEO Director 10% owner
Sell
-979 @ $0.44
($430.86)
 1,139,915 (-0.09%) Direct